相关实验视频
Updated: Jul 29, 2025

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
老年住院患者吸气性肺炎后的长期存活率:一项比较研究
Alain Putot1, Sophie Putot2, Patrick Manckoundia3
1Service de Médecine Interne Gériatrie, Pôle Personnes Agées, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France; Service de Médecine Interne et Maladies Infectieuses, Hôpitaux du Pays du Mont Blanc, Sallanches, France; Physiopathologie et Epidémiologie Cérébro-Cardiovasculaires (PEC2), Université de Bourgogne Franche Comte, Dijon, France.
吸气性肺炎 (AsP) 在老年住院患者中显著增加短期死亡率. 然而,ASP幸存者与其他患者的长期存活率相似,突出显示了早期干预的必要性.
科学领域:
- 老年病的医生 老年病的医生
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 吸气性肺炎 (ASP) 是老年人死亡的主要原因,但研究不足.
- 在老年住院患者中评估ASP的短期和长期预后至关重要.
研究的目的:
- 评估老年住院患者吸气性肺炎 (ASP) 的短期和长期预后.
- 在老年人群中,将ASP的结果与其他肺炎和一般住院病例进行比较.
主要方法:
- 对75岁及以上的患者进行了回顾性队列研究,这些患者在一年内入院于急性老年病房.
- 在ASP,非ASP和其他住院患者之间比较临床特征和2年生存期.
主要成果:
- 与非ASP患者 (15%,56%) 和其他患者 (11%,49%) 相比,ASP患者 (39/125) 的30天 (31%) 和2年 (69%) 死亡率更高.
- 经调整后的分析证实,ASP与死亡率有显著的相关性 (aHR为30天后3.09,2年后1.67).
- 在三个组中,在30天的幸存者中没有观察到长期死亡率的显著差异.
结论:
- 住院的老年患者中,有三分之一的ASP患者在30天内死亡.
- 对于在最初的30天内生存下来的ASP患者来说,长期死亡风险与其他住院的老年患者相美.
- 优化ASP早期管理策略对于改善这一脆弱人群的结果至关重要.
更多相关视频
07:27Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
09:16Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
Published on: February 26, 2017
相关概念视频
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...